Navigation Links
Experimental treatment halts hypoxic-ischemic brain injury in newborns
Date:7/29/2009

CINCINNATI Inhibiting an enzyme in the brains of newborns suffering from oxygen and blood flow deprivation stops a type of brain damage that is a leading cause of cerebral palsy, mental retardation and death, according to researchers at Cincinnati Children's Hospital Medical Center.

Reporting their results in the Journal of Neuroscience, the scientists show blocking the brain enzyme, tissue-type plasminogen activator (tPA), prevents progressive brain damage triggered by the lack of oxygen and blood supply. The experimental pre-clinical treatment involved putting a naturally occurring substance called plasminogen activator inhibitor-1 (PAI-1) into the brains of newborn rats, said Chia-Yi Kuan, M.D. PhD, senior investigator on the study and a researcher in the divisions of Developmental Biology and Neurology at Cincinnati Children's.

Besides demonstrating the brain's plasminogen activator system plays a pivotal role in neonatal cerebral hypoxic-ischemic brain injury, Dr. Kuan said the study also shows this system may be a promising therapeutic target in infants suffering hypoxic-ischemic encephalopathy (HIE). Identification of a treatment target is a vital step to finding better ways to treat newborns with HIE.

"Not only is hypoxic-ischemic encephalopathy an important cause of perinatal mortality and permanent neurological morbidities, but there are no specific medications against HIE in current medical practice," explained Ton J. DeGrauw, M.D., Ph.D., director of Neurology at Cincinnati Children's. "This is why the findings of this study may have important clinical implications because, in a rodent model of HIE, they that show inhibiting plasminogen activators in functional areas of the brain is powerful strategy for brain protection."

Earlier studies have pointed to the role certain brain proteases, or enzymes, play in adult brain injury following stroke, but very little has been known about what these enzymes do in
'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 40 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans
2. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
3. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize
4. Experimental chemotherapy regimen shows promise in treating advanced lung cancer
5. Experimental Biology and Medicine announces expansion into Asia, opens new office
6. Translational research patented first experimental treatment against idiopathic pulmonary fibrosis
7. Experimental Biology 2008 meets in San Diego April 5-9
8. Discovery to aid in future treatments of third-world parasites
9. ISU researchers find possible treatment for spinal muscular atrophy
10. Promising new treatment for Alzheimers suggested based on Hebrew University research
11. New technique can fast-track better ionic liquids for biomass pre-treatments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wi...a report revealing that the last remaining populat...cantly due to the rising tide of poaching and habi... help inform Russian officials of what needs to be...d,s biggest cat. , The report was r...
(Date:11/23/2009)...INNATINew research presents strong evidence that t...both outdoor traffic-related pollution and indoor ...n one or the other exposure alone. , Environme...nati (UC) College of Medicine have shown that chil...d particles and indoor endotoxin during early life...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Predictors of disease behavior change in Crohn 26 23146 3Bs disease 54046 1Estrogen dependent switch tempers killing activity of immune cells 9527 1Estrogen dependent switch tempers killing activity of immune cells 9527 2STAT3 gene regulates cancer stem cells in brain cancer 9525 1STAT3 gene regulates cancer stem cells in brain cancer 9525 2
...terdam, 2 December 2008 - Elsevier is delighted to...e the official publisher of the quarterly peer-rev... ( www.elsevier.com/locate/esd ) on behalf of the ...nable development involves meeting present human n...ons. Energy is central to providing many of these ...
... Arctic is undergoing rapid transformation due to ...s ERS and Envisat satellites have been providing s... These long term data sets in combination with ESA... newly adopted European Commission policy called ,...policy highlights new opportunities in the region ...
...PEL HILL How marine animals find their way back t...ross thousands of miles of open ocean has mystifie...iologists at the University of North Carolina at C... the secret. , At the beginning of their lives, s...of their home area and "imprint" on it, according ...
Other Biology News:New publishing partnership for Energy for Sustainable Development 2ESA satellites focusing on the Arctic 2No place like home: New theory for how salmon, sea turtles find their birthplace 2No place like home: New theory for how salmon, sea turtles find their birthplace 3
(Date:11/24/2009)...24/PRNewswire-FirstCall/--Sigma-AldrichCorporation...renceonTuesday,December1stat1:45PMGMTinLondon,7:45...adcastovertheInternetavailableat http://inve s ...ebcast"icontoaccessthisfile. ,, AboutSigma-Al...echnologycompany.Itschemicalandbiochemicalproducts...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Na...elopingandcommercializingnovelpainmanagementtherap...hiefExecutiveOfficer,isscheduledtopresentatthe21st...ember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewY...ncialOfficer,willbeavailabletorespondtoquestionsdu...
(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...
(Date:11/24/2009)...alif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,...nomicHealth,sExecutiveChairman,willpresentatthe21s...tyonTuesday,December1,2009at10:00a.m.ET. ,, Toa...sentation,visittheInvestorRelationssectionofGenomi...om .Pleaseconnecttothewebsiteatleast15minutesprior...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...h,announced that Sustenex(TM), its all-natural dai...e. Each Sustenex(TM) capsule contains at least 2,b...rietary, patented strain,of Bacillus coagulans des.... Sustenex(TM) with GanedenBC30 Probiotic is desig...elivering ten times more probiotic cells,than most...
...egic and operational leadership to support expans... opportunities, COLUMBIA, Md., A...ent of Brad L. Stewart as President of the Company...elops and manufactures research and in,vitro diagn... assay,cell-mediated immunity (CMI)., (Photo: ht...
...e,Chairman and CEO, Egenix, Inc., announced the ap...e company,s scientific advisory board. Dr.,Petryla...Columbia,University Medical Center where he is Dir...l Oncology. He is the co-author of numerous peer r... in the treatment of cancers of,prostate, kidney, ...
Other Biology Technology:Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 2Ganeden Biotech Takes Sustenex(TM) National with GanedenBC30 Probiotic 3Cylex Announces Brad L. Stewart as President of the Company 2
Toxoplasma IgG ELISA Kit, Single from Bio-Quant Inc.
Agarose, low melting/gelling temperature high MW separation (> 1000 bp) from GE Healthcare, formerly Amersham Biosciences
Rubella IgM ELISA Kit, Single from Bio-Quant Inc.
Chlamydia pneumonia IgA ELISA Kit, Single from Bio-Quant Inc.
Biology Products: